Details of Epigenetic Molecule(EM)
General Information of EM (ID: EM12272) | |||||||
---|---|---|---|---|---|---|---|
Official Symbol |
NTRK1
|
||||||
Official Full Name |
Neurotrophic Receptor Tyrosine Kinase 1
|
||||||
Synonym |
Neurotrophic Receptor Tyrosine Kinase 1;TRK;MTC;TRKA;High Affinity Nerve Growth Factor Receptor;Neurotrophic Tyrosine Kinase, Receptor, Type 1;TRK1-Transforming Tyrosine Kinase Protein;Tropomyosin-Related Kinase A;Tyrosine Kinase Receptor A;Trk-A;Neurotrophic Tyrosine Kinase Receptor Type 1
|
||||||
Molecule Type |
Protein coding
|
||||||
Position On Chromosome |
chr1(Start:156815640 - End:156881850)
|
||||||
Strand |
+
|
||||||
Uniprot Entry | |||||||
ENSG ID | |||||||
Disease Relevance (Click to Show/Hide) | |||||||
2C30: Melanoma of skin | Cutaneous Melanoma [Melanoma of skin] | ||||||
Detailed Information |
Disease Link
![]() |
||||||
8A01: Choreiform disorders | Huntington's disease (HD) [Choreiform disorders] | ||||||
Detailed Information |
Disease Link
![]() |
||||||
8A20: Alzheimer disease | Alzheimer's disease [Alzheimer disease] | ||||||
Detailed Information |
Disease Link
![]() |
||||||
CB03: Idiopathic interstitial pneumonitis | Idiopathic pulmonary fibrosis (IPF) [Idiopathic interstitial pneumonitis] | ||||||
Detailed Information |
Disease Link
![]() |
||||||
LD2C: Overgrowth syndromes | Sotos syndrome(SS) [Overgrowth syndromes] | ||||||
Detailed Information |
Disease Link
![]() |
||||||
SE30: Developmental delay disorder | CHARGE and Kabuki syndromes [Developmental delay disorder] | ||||||
Detailed Information |
Disease Link
![]() |
||||||
XH4XG8: Chronic myeloid leukaemia | Chronic Phase-Chronic Myeloid Leukemia [Chronic myeloid leukaemia] | ||||||
Detailed Information |
Disease Link
![]() |
Metabolite(s) with this epigenetic modification | |||||||
---|---|---|---|---|---|---|---|
Metabolite Name: Resveratrol | |||||||
Detailed Information |
Meta Info
![]() |
[1], [2] | |||||
Description |
Resveratrol could change tumor suppressor gene NTRK1 from hypomethylated to hypermethylated status in MDA-MB-231 breast cancer cells treated with resveratrol (100 M) at 48 h.
|
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.